Interstitial pneumonitis related to rituximab therapy.

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey, Sharlene Litchy, Daniel C. Scullin, James D. Bearden, Paul Richards, F. Anthony Greco, Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma Blood. ,vol. 95, pp. 3052- 3056 ,(2000) , 10.1182/BLOOD.V95.10.3052.010K30_3052_3056

Jeremy J. Erasmus, H. Page McAdams, Santiago E. Rossi, Drug-induced lung injury Seminars in Roentgenology. ,vol. 37, pp. 72- 81 ,(2002) , 10.1053/SROE.2002.0000

Jacques Bienvenu, Roland Chvetzoff, Gilles Salles, Cécile Balter, Hervé Tilly, Raoul Herbrecht, Pierre Morel, Pierre Lederlin, Philippe Solal-Celigny, Bruno Audhuy, Bernard Christian, Jean Gabarre, Olivier Casasnovas, Gérald Marit, Catherine Sebban, Bertrand Coiffier, Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematology Journal. ,vol. 2, pp. 378- 384 ,(2001) , 10.1038/SJ.THJ.6200133

Joanne R. Cleverley, Nicholas J. Screaton, Melanie P. Hiorns, Julia D.A. Flint, Nestor L. Müller, Drug-induced lung disease: high-resolution CT and histological findings. Clinical Radiology. ,vol. 57, pp. 292- 299 ,(2002) , 10.1053/CRAD.2001.0792

Bertrand Coiffier, Eric Lepage, Josette Brière, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard, Felix Reyes, Pierre Lederlin, Christian Gisselbrecht, CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma The New England Journal of Medicine. ,vol. 346, pp. 235- 242 ,(2002) , 10.1056/NEJMOA011795

A Fassas, I Gojo, A Rapoport, M Cottler-Fox, B Meisenberg, JC Papadimitriou, G Tricot, Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy. Bone Marrow Transplantation. ,vol. 28, pp. 399- 403 ,(2001) , 10.1038/SJ.BMT.1703147